Issued Patents All Time
Showing 1–25 of 31 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12370197 | Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases | Yifan Zhai, Douglas Dong FANG, Qiuqiong Tang | 2025-07-29 |
| 12343352 | N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors | Yifan Zhai, Zi CHEN | 2025-07-01 |
| 12287338 | Method and compositions for predicting anti-cancer efficacy of compounds targeting apoptosis pathway | Yifan Zhai, Douglas Dong FANG, Ran Tao | 2025-04-29 |
| 12268665 | Combination of immunotherapies with MDM2 inhibitors | Yifan Zhai, Douglas Dong FANG, Qiuqiong Tang | 2025-04-08 |
| 12233047 | Pharmaceutical combination and use thereof | Yifan Zhai, Douglas Dong FANG, Qiuqiong Tang | 2025-02-25 |
| 12194024 | Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating disease | Yifan Zhai, Qiuqiong Tang, Douglas Dong FANG, Jing Deng | 2025-01-14 |
| 12186304 | Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule | Yifan Zhai, Douglas Dong FANG, Guangfeng Wang, Qiuqiong Tang, Wentao Pan +1 more | 2025-01-07 |
| 12083136 | Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereof | Yifan Zhai, Guangfeng Wang, Douglas Dong FANG, Jing Deng, Miaozhen QIU +1 more | 2024-09-10 |
| 11850239 | MDM2 inhibitor and a platinum compound for cancer treatment | Yifan Zhai | 2023-12-26 |
| 11554127 | Synergistic antitumor effect of Bcl-2 inhibitor combined with rituximab and/or bendamustine or Bcl-2 inhibitor combined with CHOP | Yifan Zhai, Guangfeng Wang | 2023-01-17 |
| 11491168 | Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof | Yifan Zhai | 2022-11-08 |
| 11491167 | Combination product of Bcl-2 inhibitor and chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases | Yifan Zhai, Guangfeng Wang | 2022-11-08 |
| 11478477 | Method for treating cancer by combination of FAK/ALK/ROS1 inhibitor and EGFR inhibitor | Yifan Zhai, Douglas Dong FANG, Guangfeng Wang | 2022-10-25 |
| 11478470 | Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibitor and BTK inhibitor and use thereof in the prevention and/or treatment of diseases | Yifan Zhai, Douglas Dong FANG, Guangfeng Wang, Guoqin Zhai | 2022-10-25 |
| 11478469 | Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseases | Yifan Zhai, Qiuqiong Tang, Douglas Dong FANG | 2022-10-25 |
| 11452716 | Pharmaceutical composition and use thereof | Yifan Zhai, Douglas Dong FANG, Qiuqiong Tang | 2022-09-27 |
| 11395815 | Compound for treating osteoarthritis | Yifan Zhai, Douglas Dong FANG, Saijie ZHU | 2022-07-26 |
| 11298339 | Bisdiazabicyclo compound for treatment and/or prevention of hepatitis virus-related diseases or disorders | Yifan Zhai, Xiaoyong Zhang, Jinlin Hou | 2022-04-12 |
| 9783539 | Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors | Jianyong Chen, Yunlong Zhou, Shaomeng Wang, Ming Guo, Lingling Jiao +6 more | 2017-10-10 |
| 8557812 | Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof | Shaomeng Wang, Guoping Wang, Guozhi Tang, Renxiao Wang, Zaneta Nikolovska-Coleska +1 more | 2013-10-15 |
| 8163805 | Small molecule antagonists of Bcl-2 family proteins | Shaomeng Wang, Liang Xu | 2012-04-24 |
| 7910621 | Small molecule antagonists of XIAP family proteins | Jianyong Chen, Zaneta Nikolovska-Coleska, Shaomeng Wang, Haiying Sun, Liang Xu +1 more | 2011-03-22 |
| 7825216 | Phenylanine derivatives | Terrence R. Burke, Jr., Yang Gao, Zhu-jun Yao | 2010-11-02 |
| 7432304 | Small molecule antagonists of Bcl-2 family proteins | Shaomeng Wang, Liang Xu | 2008-10-07 |
| 7427689 | ErbB-2 selective small molecule kinase inhibitors | Shaomeng Wang, Istvan Enyedy | 2008-09-23 |